ARTICLE
18 October 2018

"Do What Jesus Would Do" Organ Donor Ad Sparks Controversy In Australia

FK
Frankfurt Kurnit Klein & Selz

Contributor

Frankfurt Kurnit provides high quality legal services to clients in many industries and disciplines worldwide. With leading practices in entertainment, advertising, IP, technology, litigation, corporate, estate planning, charitable organizations, professional responsibility and other areas — Frankfurt Kurnit helps clients face challenging legal issues and meet their goals with efficient solutions.
Dying to Live said, "No doubt this will create some heated discussion.
Australia Media, Telecoms, IT, Entertainment

Dying to Live, a group that promotes organ donation, has sparked controversy over a commercial it released in Australia which features guards suggesting to Jesus, while he is on the cross, that he become an organ donor.  

In the commercial, Jesus asks, "Is this really the best time to bring this up?"  The guard replies, "We get it.  You know, no one wants to talk about death."  Jesus then agrees and the guards help him sign up as an organ donor online.  After that, the guards ask Jesus if they could take a selfie with him.

Dying to Live said, "No doubt this will create some heated discussion.  And that's exactly the point of it all.  To get people to talk about organ donation."

According to various media reports, Ad Standards, Australia's advertising self-regulation system, has already received complaints about the commercial, and other community and religious figures have raised concerns as well.

www.fkks.com

This alert provides general coverage of its subject area. We provide it with the understanding that Frankfurt Kurnit Klein & Selz is not engaged herein in rendering legal advice, and shall not be liable for any damages resulting from any error, inaccuracy, or omission. Our attorneys practice law only in jurisdictions in which they are properly authorized to do so. We do not seek to represent clients in other jurisdictions.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More